IL162819A0 - Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus - Google Patents

Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus

Info

Publication number
IL162819A0
IL162819A0 IL16281903A IL16281903A IL162819A0 IL 162819 A0 IL162819 A0 IL 162819A0 IL 16281903 A IL16281903 A IL 16281903A IL 16281903 A IL16281903 A IL 16281903A IL 162819 A0 IL162819 A0 IL 162819A0
Authority
IL
Israel
Prior art keywords
spray
drying apparatus
dried solid
solid amorphous
amorphous drug
Prior art date
Application number
IL16281903A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL162819A0 publication Critical patent/IL162819A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/02—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/04—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a gaseous medium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Glanulating (AREA)
  • Disintegrating Or Milling (AREA)
  • Drying Of Solid Materials (AREA)
IL16281903A 2002-02-01 2003-01-20 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus IL162819A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35408002P 2002-02-01 2002-02-01
PCT/IB2003/000144 WO2003063822A2 (fr) 2002-02-01 2003-01-20 Procede de fabrication de dispersions medicamenteuses amorphes solides homogenes sechees par pulverisation au moyen d'un appareil de sechage par pulverisation modifie

Publications (1)

Publication Number Publication Date
IL162819A0 true IL162819A0 (en) 2005-11-20

Family

ID=27663286

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16281903A IL162819A0 (en) 2002-02-01 2003-01-20 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus

Country Status (23)

Country Link
US (6) US6763607B2 (fr)
EP (1) EP1469833B1 (fr)
JP (2) JP4865989B2 (fr)
KR (1) KR100664822B1 (fr)
CN (1) CN1309370C (fr)
BR (1) BR0307333A (fr)
CA (1) CA2472028C (fr)
ES (1) ES2878403T3 (fr)
GT (1) GT200300018A (fr)
HK (1) HK1074164A1 (fr)
HN (1) HN2003000053A (fr)
IL (1) IL162819A0 (fr)
MX (1) MXPA04007433A (fr)
PA (1) PA8565301A1 (fr)
PE (1) PE20030805A1 (fr)
PL (1) PL372247A1 (fr)
PT (1) PT1469833T (fr)
RS (1) RS61604A (fr)
RU (1) RU2278659C9 (fr)
TW (1) TW200302749A (fr)
UY (1) UY27640A1 (fr)
WO (1) WO2003063822A2 (fr)
ZA (1) ZA200404882B (fr)

Families Citing this family (133)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6924133B1 (en) * 1999-10-01 2005-08-02 Novozymes A/S Spray dried enzyme product
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US7115279B2 (en) 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
WO2003000226A2 (fr) * 2001-06-22 2003-01-03 Pfizer Products Inc. Compositions pharmaceutiques contenant des ensembles polymere et medicament
DE60233874D1 (de) * 2001-06-22 2009-11-12 Pfizer Prod Inc Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren
US20050249786A1 (en) * 2001-09-28 2005-11-10 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
US20050227911A1 (en) * 2001-09-28 2005-10-13 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
US20050233003A1 (en) * 2001-09-28 2005-10-20 Solubest Ltd. Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
US20050191359A1 (en) * 2001-09-28 2005-09-01 Solubest Ltd. Water soluble nanoparticles and method for their production
US20050226934A1 (en) * 2001-09-28 2005-10-13 Solubest Ltd. Inclusion complexes of active compounds in acrylate (co)polymers and methods for their production
WO2003063822A2 (fr) 2002-02-01 2003-08-07 Pfizer Products Inc. Procede de fabrication de dispersions medicamenteuses amorphes solides homogenes sechees par pulverisation au moyen d'un appareil de sechage par pulverisation modifie
CA2474958A1 (fr) * 2002-02-01 2003-08-07 Pfizer Products Inc. Procede de fabrication de dispersions medicamenteuses amorphes solides homogenes sechees par pulverisation au moyen de buses de projection
BR0313428A (pt) * 2002-08-12 2005-06-28 Pfizer Prod Inc Composições farmacêuticas de drogas semi-ordenados e polìmeros
US20040242670A1 (en) * 2003-06-02 2004-12-02 Sonny Sebastian Process for preparation of amorphous atorvastatin calcium
EP1546146A1 (fr) * 2003-06-03 2005-06-29 Teva Pharmaceutical Industries Limited Formes polymorphes de ziprasidone chlorhydrate et procedes pour leur elaboration
US7344491B1 (en) 2003-11-26 2008-03-18 Nanobiomagnetics, Inc. Method and apparatus for improving hearing
US8651113B2 (en) * 2003-06-18 2014-02-18 Swr&D Inc. Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
US7723311B2 (en) * 2003-06-18 2010-05-25 Nanobiomagnetics, Inc. Delivery of bioactive substances to target cells
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
JP2007517016A (ja) * 2003-12-31 2007-06-28 ファイザー・プロダクツ・インク 低溶解性薬剤及びポロキサマーの固体組成物
DE602004031767D1 (de) * 2003-12-31 2011-04-21 Bend Res Inc Stabilisierte pharmazeutische feste zusammensetzungen von arzneimitteln mit geringer löslichkeit, poloxameren und stabilisierenden polymeren
US20050163906A1 (en) * 2004-01-28 2005-07-28 Guillermo Silva Coconut beverage and method of producing the same
EP1753402B1 (fr) 2004-05-28 2008-10-01 Pfizer Products Incorporated Compositions pharmaceutiques aux performances accrues comprenant un polymère hpmca
MXPA06010084A (es) 2004-06-01 2007-03-01 Teva Gyogyszergyar Zartkoruen Proceso para la preparacion de forma amorfa de un farmaco.
CN1307974C (zh) * 2004-08-10 2007-04-04 上海信谊康捷药业有限公司 含极微量药物的制剂生产工艺
WO2006060616A1 (fr) 2004-12-01 2006-06-08 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Procedes de production de macrolides cristallins
WO2006062980A2 (fr) * 2004-12-07 2006-06-15 Nektar Therapeutics Formulation non cristalline stable comprenant de la tiagabine
EP2548894A1 (fr) 2005-02-03 2013-01-23 Bend Research, Inc. Compositions pharmaceutiques à éfficacité améliorée
US20060270685A1 (en) * 2005-03-14 2006-11-30 Judith Aronhime Anhydrous ziprasidone mesylate and a process for its preparation
EP1858891A2 (fr) * 2005-03-14 2007-11-28 Teva Pharmaceutical Industries Ltd. Formes cristallines de mesylate de ziprasidone
CA2608952A1 (fr) * 2005-05-19 2006-11-23 Dwayne Thomas Friesen Compositions pharmaceutiques comprenant une forme d'un inhibiteur vegf-r
CN101277682B (zh) * 2005-07-28 2015-07-29 Isp投资有限公司 无定形依发韦仑及其生产
WO2007056205A2 (fr) * 2005-11-04 2007-05-18 Eastman Chemical Company Esters de carboxyalkylcellulose pour administration d'agents pharmaceutiquement actifs peu solubles
TW201414469A (zh) * 2006-03-20 2014-04-16 Vertex Pharma 對包括ｖｘ-９５０之藥物實施噴霧乾燥之方法及由此方法製備之產物
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
PE20081457A1 (es) * 2006-10-06 2008-10-18 Organon Nv Asenapina amorfa, procesos para prepararlas y su uso para tratar trastornos del sistema nervioso central
US20080085315A1 (en) * 2006-10-10 2008-04-10 John Alfred Doney Amorphous ezetimibe and the production thereof
US20080181948A1 (en) * 2006-11-15 2008-07-31 Abbott Laboratories Solid pharmaceutical dosage formulations
US20080152717A1 (en) * 2006-12-14 2008-06-26 Isp Investments, Inc. Amorphous valsartan and the production thereof
US8613946B2 (en) * 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
KR101508966B1 (ko) * 2006-12-29 2015-04-06 바셀 폴리올레핀 이탈리아 에스.알.엘 폴리머를 건조시키기 위한 공정 및 장치
WO2008092046A2 (fr) * 2007-01-26 2008-07-31 Isp Investments Inc. Oxcarbazépine amorphe et sa préparation
EP2125938A2 (fr) * 2007-01-26 2009-12-02 Isp Investments Inc. Procédé de traitement de formulation pour produire des produits séchés pour une pulvérisation
DK2158029T3 (da) * 2007-04-10 2019-08-19 Gea Process Eng Inc Procesgasfilter og fremgangsmåde til rensning af dette
US20080287519A1 (en) 2007-05-01 2008-11-20 Marioara Mendelovici Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
US8256134B2 (en) * 2007-06-25 2012-09-04 Pulse Holdings LLC Drying apparatus and methods for ethanol production
US7937850B2 (en) * 2007-06-25 2011-05-10 J. Jireh Holdings Llc Methods and apparatus for drying condensed distiller's solubles (CDS) to produce dried distiller's solubles (DDS)
US8347525B2 (en) * 2007-09-24 2013-01-08 Inhalation Sciences Sweden Ab System and method for producing dry formulations
US8517723B2 (en) 2007-10-01 2013-08-27 Pulse Holdings, LLC Methods for drying a viral vaccine
TWI435726B (zh) * 2007-10-17 2014-05-01 Todd F Ovokaitys 室溫下穩定之非晶形阿斯匹靈及其製備方法
BRPI0818575A2 (pt) * 2007-10-17 2014-10-07 Todd F Ovokaitys Processo para a modificação do estado sólido de um composto e composições co-amorfas produzidas com o mesmo
US8268354B2 (en) 2007-11-07 2012-09-18 Aridis Pharmaceuticals Sonic low pressure spray drying
KR100917185B1 (ko) 2007-11-13 2009-09-15 (주)아모레퍼시픽 고분자 입자제조장치, 고분자입자 제조방법 및 이 방법에의해 제조된 고분자 입자를 포함하는 조성물
WO2009085637A1 (fr) * 2007-12-21 2009-07-09 Url Pharma, Inc. Métaxalone amorphe et ses dispersions amorphes
US7988074B2 (en) * 2008-03-05 2011-08-02 J. Jireh Holdings Llc Nozzle apparatus for material dispersion in a dryer and methods for drying materials
US20100048913A1 (en) 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens;Synthesis In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
SE532388C2 (sv) * 2008-03-14 2010-01-12 Tetra Laval Holdings & Finance Förpackningslaminat och -behållare med två separata gasbarriärskikt samt metod för deras framställning
EP3023433A1 (fr) 2009-02-05 2016-05-25 Tokai Pharmaceuticals, Inc. Nouveaux promédicaments d'inhibiteurs cyp17/anti-androgènes stéroïdiens
EP3130396B1 (fr) 2009-03-27 2021-03-17 Bend Research, Inc. Procédé de séchage par pulvérisation
PT2442791T (pt) 2009-06-16 2020-02-06 Pfizer Formas farmacêuticas de apixaban
AU2011264993B2 (en) 2010-06-09 2014-02-06 Abbvie Bahamas Ltd. Solid dispersions containing kinase inhibitors
WO2011154014A1 (fr) * 2010-06-11 2011-12-15 Gea Process Engineering A/S Séchage contrôlé de l'humidité
PT2611530T (pt) 2010-09-03 2019-05-09 Bend Res Inc Aparelho de secagem por pulverização e métodos de utilização do mesmo
WO2012031129A2 (fr) 2010-09-03 2012-03-08 Bend Research, Inc. Appareil de séchage par pulvérisation et ses procédés d'utilisation
EP2618924A1 (fr) * 2010-09-24 2013-07-31 Bend Research, Inc. Procédé et appareil de séchage par pulvérisation à température élevée
US8939388B1 (en) 2010-09-27 2015-01-27 ZoomEssence, Inc. Methods and apparatus for low heat spray drying
US9332776B1 (en) 2010-09-27 2016-05-10 ZoomEssence, Inc. Methods and apparatus for low heat spray drying
EP2654939A2 (fr) * 2010-12-21 2013-10-30 President and Fellows of Harvard College Techniques de séchage par atomisation
EP2661254B1 (fr) 2011-01-05 2017-08-02 Hospira, Inc. Séchage par atomisation de la vancomycine
EP2654726A4 (fr) 2011-03-08 2013-10-30 Zalicus Pharmaceuticals Ltd Formulations de dispersions solides et leurs procédés d'utilisation
MX2014008008A (es) * 2011-12-29 2014-08-21 Abbvie Inc Composiciones solidas que comprenden un inhibidor del virus de la hepatitis c.
BR112014028593A2 (pt) 2012-05-17 2017-12-19 Genentech Inc forma amorfa de um composto de pirimidinil-ciclopentano inibidor de akt, composições e métodos dos mesmos"
EP2745901A1 (fr) * 2012-12-19 2014-06-25 Urea Casale SA Procédé de transformation d'une tour de solidification, en particulier dans une installation pour la synthèse de l'urée
SI2950786T1 (sl) 2013-01-31 2020-03-31 Gilead Pharmasset Llc Formulacija kombinacije dveh protivirusnih spojin
EP2950797B1 (fr) 2013-02-01 2019-09-11 Glialogix, Inc. Compositions et méthodes utilisables en vue du traitement de maladies neurodégénératives et autres
CA2904170A1 (fr) 2013-03-14 2014-09-25 University Of Maryland, Baltimore Agents de diminution du recepteur des androgenes et leurs utilisations
CN104043104B (zh) 2013-03-15 2018-07-10 浙江创新生物有限公司 含盐酸万古霉素的喷雾干粉及其工业化制备方法
KR20160058774A (ko) 2013-08-12 2016-05-25 토카이 파마슈티컬, 아이엔씨. 안드로겐-표적 치료제를 이용하는 종양 질환 치료를 위한 바이오마커
WO2015030854A1 (fr) 2013-08-27 2015-03-05 Gilead Pharmasset Llc Formulation de dispersion orale d'un composé antiviral
ES2900570T3 (es) 2013-08-27 2022-03-17 Gilead Pharmasset Llc Formulación de combinación de dos compuestos antivirales
US9511341B2 (en) * 2013-08-30 2016-12-06 Sunny Pharmtech Inc. Method for preparing acetazolamide sodium powder
US20160296463A1 (en) * 2013-11-11 2016-10-13 Impax Laboratories, Inc. Rapidly disintegrating formulations and methods thereof
PT107568B (pt) * 2014-03-31 2018-11-05 Hovione Farm S A Processo de secagem por atomização para a produção de pós com propriedades melhoradas.
PT107567B (pt) * 2014-03-31 2019-02-13 Hovione Farm S A Secador por atomização com atomizador múltiplo, método para o aumento de escala de pós para inalação secos por dispositivo de atomização múltiplo e uso de vários atomizadores num secador por atomização
US10076512B2 (en) 2014-05-01 2018-09-18 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
US11311519B2 (en) 2014-05-01 2022-04-26 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
US10202598B2 (en) 2014-05-30 2019-02-12 Todd Frank Ovokaitys Methods and systems for generation, use, and delivery of activated stem cells
WO2015187974A1 (fr) 2014-06-06 2015-12-10 Ovokaitys Todd Frank Procédés et compositions pour augmenter l'activité biologique de nutriments
US10384985B2 (en) 2014-06-06 2019-08-20 B.K. Consultants, Inc. Methods and compositions for increasing the yield of, and beneficial chemical composition of, certain plants
US9561184B2 (en) 2014-09-19 2017-02-07 Velico Medical, Inc. Methods and systems for multi-stage drying of plasma
EP3212169B1 (fr) 2014-10-31 2021-01-13 Bend Research, Inc. Procédé de formation de domaines actifs dispersés dans une matrice
IL235751A0 (en) * 2014-11-18 2015-02-26 Omrix Biopharmaceuticals Ltd An addition to the spray dryer
CN107530338B (zh) 2015-04-21 2020-12-01 艾格尔峰生物制药有限公司 包含洛那法尼和利托那韦的药物组合物
US20170135969A1 (en) 2015-11-12 2017-05-18 Jds Therapeutics, Llc Topical arginine-silicate-inositol for wound healing
WO2017173111A1 (fr) 2016-03-31 2017-10-05 Takeda Pharmaceutical Company Limited Complexes isoquinoléinyle-triazolone
SG11201808949SA (en) 2016-04-15 2018-11-29 Novira Therapeutics Inc Combinations and methods comprising a capsid assembly inhibitor
US20170296993A1 (en) * 2016-04-18 2017-10-19 Premex S.A. Multiple modular system for the formation of particles in powder and microcapsule form for different processes
US10967345B2 (en) 2016-04-18 2021-04-06 Premex S.A.S. Multiple modular system for the formation of particles in powder and microcapsule form for different processes
GB201609222D0 (en) 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
BR102017011025A2 (pt) 2016-06-02 2017-12-19 Gilead Pharmasset Llc Formulation of combination of three antiviral compounds
AU2017318672B2 (en) 2016-09-01 2022-03-10 Nutrition 21, Llc Magnesium biotinate compositions and methods of use
WO2018075865A1 (fr) 2016-10-21 2018-04-26 Glialogix, Inc. Compositions de traitement de maladies neurodégénératives
US10155234B1 (en) 2017-08-04 2018-12-18 ZoomEssence, Inc. Ultrahigh efficiency spray drying apparatus and process
US9861945B1 (en) 2017-08-04 2018-01-09 ZoomEssence, Inc. Ultrahigh efficiency spray drying apparatus and process
US9993787B1 (en) 2017-08-04 2018-06-12 ZoomEssence, Inc. Ultrahigh efficiency spray drying apparatus and process
MX2020001407A (es) 2017-08-04 2020-07-14 Zoomessence Inc Aparato y proceso de secado por pulverizacion de ultra alta eficiencia.
US10486173B2 (en) 2017-08-04 2019-11-26 ZoomEssence, Inc. Ultrahigh efficiency spray drying apparatus and process
CN107843102A (zh) * 2017-11-29 2018-03-27 成都市菜达人农业科技有限公司 一种离心式大米烘干装置
US20190231705A1 (en) * 2018-01-29 2019-08-01 Merck Sharp & Dohme Corp. High drug load polymeric nanoparticle formulations and methods of making and using same
SG11202007198WA (en) 2018-01-31 2020-08-28 Deciphera Pharmaceuticals Llc Combination therapy for the treatment of gastrointestinal stromal tumors
CA3089630A1 (fr) 2018-01-31 2019-08-08 Deciphera Pharmaceuticals, Llc Polytherapie pour le traitement de la mastocytose
CA3090125A1 (fr) 2018-03-14 2019-09-19 Janssen Sciences Ireland Unlimited Company Schema posologique de modulateur d'assemblage de capside
US10569244B2 (en) 2018-04-28 2020-02-25 ZoomEssence, Inc. Low temperature spray drying of carrier-free compositions
MX2021005213A (es) 2018-11-02 2021-09-08 Nutrition 21 Llc Composiciones que contienen complejos de silicato de arginina estabilizado con inositol y inositol para mejorar funciones cognitivas en jugadores de videojuegos.
US12102646B2 (en) 2018-12-05 2024-10-01 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis and inflammation
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection
TW202122082A (zh) 2019-08-12 2021-06-16 美商迪賽孚爾製藥有限公司 治療胃腸道基質瘤方法
EP4013412A1 (fr) 2019-08-12 2022-06-22 Deciphera Pharmaceuticals, LLC Ripretinib pour le traitement de tumeurs stromales gastro-intestinales
CA3165102A1 (fr) 2019-12-16 2021-06-24 Nutrition 21, Llc Procedes de production de complexes d'arginine-silicate
TW202136257A (zh) 2019-12-30 2021-10-01 美商迪賽孚爾製藥有限公司 非晶形激酶抑制劑調配物及其使用方法
EP4084778B1 (fr) 2019-12-30 2023-11-01 Deciphera Pharmaceuticals, LLC Formulations d'inhibiteur de kinase amorphe et leurs procédés d'utilisation
EP4084779B1 (fr) 2019-12-30 2024-10-09 Deciphera Pharmaceuticals, LLC Compositions de 1-(4-bromo-5-(1-éthyl-7-(méthylamino)-2-oxo-1,2-dihydro -1,6-naphthyridine-3-yl)-2-fluorophényl)-3-phényluree
CN112539604B (zh) * 2020-11-27 2022-07-29 济南森峰激光科技股份有限公司 一种用于激光熔覆粉末的干燥装置
AU2022214447A1 (en) * 2021-01-29 2023-08-10 ChromaDex Inc. Ethyl cellulose based coatings for microencapsulation of nicotinamide riboside and other nicotinyl riboside compounds
CN114353499B (zh) * 2022-02-10 2023-01-24 安徽海蓝生物科技有限公司 一种l-酒石酸生物制备用流化床及其制备工艺
WO2023158616A1 (fr) * 2022-02-18 2023-08-24 Viking Therapeutics, Inc. FORMES POSOLOGIQUES ORALES DE L'AGONISTE DE TRβ, VK2809, POUR LE TRAITEMENT DE TROUBLES HÉPATIQUES, ET PROCÉDÉS DE PRÉPARATION DE CELLES-CI
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors
US11841189B1 (en) 2022-09-15 2023-12-12 Velico Medical, Inc. Disposable for a spray drying system
US11998861B2 (en) 2022-09-15 2024-06-04 Velico Medical, Inc. Usability of a disposable for a spray drying plasma system
US11975274B2 (en) 2022-09-15 2024-05-07 Velico Medical, Inc. Blood plasma product
US12083447B2 (en) 2022-09-15 2024-09-10 Velico Medical, Inc. Alignment of a disposable for a spray drying plasma system
CN115784980A (zh) * 2022-11-21 2023-03-14 四川尚元惠生生物科技有限公司 一种吡啶甲酸铬母液的回收处理方法

Family Cites Families (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL46210C (fr) 1936-06-19
US2460546A (en) 1942-10-01 1949-02-01 C H Wheeler Mfg Co Method and apparatus for treating materials
US2531343A (en) * 1944-12-11 1950-11-21 Swift & Co Manufacture of dried egg material
GB1131242A (en) 1965-02-18 1968-10-23 Gen Foods Ltd Improvements in or relating to spray-drying apparatus
US3324567A (en) * 1965-07-19 1967-06-13 Nat Dairy Prod Corp Drying method and apparatus
SE364170B (fr) 1969-02-01 1974-02-18 Morinaga Milk Industry Co Ltd
GB1329791A (en) 1971-01-19 1973-09-12 Niro Atomizer As Spray drying devices for the production of powder eg milk powder
IT1025765B (it) 1974-11-18 1978-08-30 Gastaldi Francesco Essiccatore perfezionato a spruzzo
US4056599A (en) 1975-10-20 1977-11-01 Bechtel International Corporation Process for the recovery of magnesium chloride hydrate and potassium chloride from carnallite and bischofite
US4344934A (en) * 1978-11-20 1982-08-17 American Home Products Corporation Therapeutic compositions with enhanced bioavailability
US4187617A (en) 1978-12-18 1980-02-12 Becker James J Jr Spray dryer
US4380491A (en) 1981-08-26 1983-04-19 Combustion Engineering, Inc. Spray nozzle assembly for spray dryer
US4865989A (en) 1981-12-22 1989-09-12 U.C. Regents Eukaryotic vectors and plasmids having PGK regulatory signals
US5209821A (en) * 1985-05-09 1993-05-11 Purdue Research Foundation Apparatus for removing volatiles from, or dehydrating, liquid products
US4702799A (en) 1985-09-03 1987-10-27 Nestec S.A. Dryer and drying method
US5227017A (en) * 1988-01-29 1993-07-13 Ohkawara Kakohki Co., Ltd. Spray drying apparatus equipped with a spray nozzle unit
IT1230095B (it) 1989-04-27 1991-10-05 Parenta Srl Procedimento per la preparazione di forme sterili di polveri iniettabili di antibiotici.
US5019400A (en) * 1989-05-01 1991-05-28 Enzytech, Inc. Very low temperature casting of controlled release microspheres
US5000947A (en) 1989-05-30 1991-03-19 Moleculon, Inc. Shaped articles containing liquefiable powders for delivery of cosmetic and other personal care agents
PT96229B (pt) 1989-12-22 1998-06-30 Syntex Pharma Int Processo para a preparacao de composicoes farmaceuticas em po, secas por pulverizacao, directamente compressiveis em comprimidos, contendo naproxeno ou naproxeno sodico
ATE118178T1 (de) 1990-11-29 1995-02-15 Faulding F H & Co Ltd Verfahren zur herstellung von flüssigkeiten enthaltenden pulvern.
KR0159947B1 (ko) 1991-03-12 1998-11-16 마사아키 오카와라 분수형 가압 2류체 노즐 장치와 그것을 편입하여 이루어지는 스프레이 드라이어 장치, 및 가압 2류체에 있어서의 액적 경 제어법
KR0182801B1 (ko) * 1991-04-16 1999-05-01 아만 히데아키 고체 분산체의 제조방법
DE4244466C2 (de) 1992-12-24 1995-02-23 Pharmatech Gmbh Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und deren Verwendung zur Herstellung von pharmazeutischen Präparaten
WO1995024599A1 (fr) * 1994-03-11 1995-09-14 Niro Holding A/S Dispositif de sechage par pulverisation
CN1096862C (zh) 1994-05-06 2002-12-25 辉瑞大药厂 阿齐霉素的控释剂型
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
JP3440623B2 (ja) * 1995-04-20 2003-08-25 三菱化学株式会社 二流体ノズルを用いる噴霧乾燥方法
US6297269B1 (en) 1995-06-06 2001-10-02 Pfizer Inc. Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
AU6003896A (en) 1995-06-08 1997-01-09 Janssen Pharmaceutica N.V. Starch microsphere anti migraine composition
NL1000611C2 (nl) * 1995-06-20 1996-12-23 Stork Friesland Bv Inrichting, alsmede werkwijze voor het bereiden van een gesproeidroogd produkt.
AUPN605795A0 (en) 1995-10-19 1995-11-09 F.H. Faulding & Co. Limited Analgesic pharmaceutical composition
DE19542442A1 (de) 1995-11-14 1997-05-15 Wacker Chemie Gmbh Verfahren zur Herstellung von in Wasser redispergierbaren, Organosiliciumverbindungen enthaltenden Pulverzusammensetzungen
US5858409A (en) * 1996-04-17 1999-01-12 Fmc Corporation Hydrolyzed cellulose granulations for pharmaceuticals
US20030064108A1 (en) 1996-04-23 2003-04-03 Stefan Lukas Taste masked pharmaceutical compositions
AUPN969796A0 (en) 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
JP3270764B2 (ja) * 1996-11-27 2002-04-02 ファイザー・インク アポｂ−分泌／ｍｔｐ阻害性アミド
ATE364374T1 (de) * 1997-08-11 2007-07-15 Pfizer Prod Inc Feste pharmazeutische dispersionen mit erhöhter bioverfügbarkeit
JP3651220B2 (ja) * 1998-01-07 2005-05-25 三菱化学株式会社 噴霧乾燥機およびこれを用いる噴霧乾燥方法
US6197786B1 (en) 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
GT199900147A (es) * 1998-09-17 1999-09-06 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas.
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
ATE404178T1 (de) 1999-02-10 2008-08-15 Pfizer Prod Inc Vorrichtung mit matrixgesteuerter wirkstofffreisetzung
EP1027888B1 (fr) 1999-02-10 2009-06-10 Pfizer Products Inc. Dispositif osmotique pour délivrer des dispersions solides amorphes des médicaments
EP1027886B1 (fr) 1999-02-10 2008-07-09 Pfizer Products Inc. Dispersions pharmaceutiques solides
US6253463B1 (en) * 1999-04-26 2001-07-03 Niro A/S Method of spray drying
AU4133899A (en) * 1999-06-08 2000-12-28 Niro A/S A process and a plant for spray drying
MXPA02002873A (es) 1999-09-16 2002-08-30 Axys Pharm Inc Compuestos y composiciones farmaceuticas como inhibidores de la catepsina s.
CO5271716A1 (es) * 1999-11-30 2003-04-30 Pfizer Prod Inc Cristales de 4- carboxamino 1,2,3,4-tetrahidroquinolina 2- sustituida
AU782469B2 (en) 1999-12-23 2005-08-04 Mayne Pharma International Pty Ltd Improved pharmaceutical compositions for poorly soluble drugs
CN1309370A (zh) 2000-02-14 2001-08-22 顾丽萍 在网络或互联网络上进行文件或数据库搜索的方法及系统
AU2001245764A1 (en) 2000-03-15 2001-09-24 Axys Pharmaceuticals, Inc. Novel compounds and compositions as protease inhibitors
AR027656A1 (es) 2000-03-16 2003-04-09 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la glucogeno-fosforilasa
US20010053791A1 (en) * 2000-03-16 2001-12-20 Babcock Walter C. Glycogen phosphorylase inhibitor
US7115279B2 (en) * 2000-08-03 2006-10-03 Curatolo William J Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
EP1186347A1 (fr) * 2000-09-05 2002-03-13 F. Hoffmann-La Roche Ag Procédé et dispositif de pulvérisation de liquides
US6848197B2 (en) 2001-04-18 2005-02-01 Advanced Inhalation Research, Inc. Control of process humidity to produce large, porous particles
WO2003000226A2 (fr) 2001-06-22 2003-01-03 Pfizer Products Inc. Compositions pharmaceutiques contenant des ensembles polymere et medicament
WO2003063822A2 (fr) 2002-02-01 2003-08-07 Pfizer Products Inc. Procede de fabrication de dispersions medicamenteuses amorphes solides homogenes sechees par pulverisation au moyen d'un appareil de sechage par pulverisation modifie
DE60322665D1 (de) 2002-02-01 2008-09-18 Pfizer Prod Inc Pharmazeutische darreichungsform mit gesteuerter freigabe eines cholesterylester-transferproteininhibitors
DE60320940D1 (de) 2002-02-01 2008-06-26 Pfizer Prod Inc Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
AR038375A1 (es) 2002-02-01 2005-01-12 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
CA2474958A1 (fr) 2002-02-01 2003-08-07 Pfizer Products Inc. Procede de fabrication de dispersions medicamenteuses amorphes solides homogenes sechees par pulverisation au moyen de buses de projection
IL163748A0 (en) 2002-03-05 2005-12-18 Merck Frosst Canada Inc Cathepsin cysteine protease inhibitors
US6820865B2 (en) 2003-01-21 2004-11-23 David Nicholson Low Nozzle valve type spray dryer
US7357849B2 (en) 2005-09-01 2008-04-15 Watervap, Llc Method and system for separating solids from liquids

Also Published As

Publication number Publication date
US8343550B2 (en) 2013-01-01
ZA200404882B (en) 2005-07-29
CN1309370C (zh) 2007-04-11
MXPA04007433A (es) 2004-10-11
RU2278659C9 (ru) 2007-02-20
WO2003063822A3 (fr) 2003-11-13
RU2004123625A (ru) 2006-01-27
US20040194338A1 (en) 2004-10-07
JP2005517689A (ja) 2005-06-16
US20110277339A1 (en) 2011-11-17
US20030163931A1 (en) 2003-09-04
HN2003000053A (es) 2003-10-09
PT1469833T (pt) 2021-07-13
KR100664822B1 (ko) 2007-01-04
RS61604A (en) 2006-10-27
CN1625389A (zh) 2005-06-08
US8828443B2 (en) 2014-09-09
PE20030805A1 (es) 2003-09-19
US20140017314A1 (en) 2014-01-16
WO2003063822A2 (fr) 2003-08-07
CA2472028A1 (fr) 2003-08-07
PL372247A1 (en) 2005-07-11
RU2278659C2 (ru) 2006-06-27
US20150028503A1 (en) 2015-01-29
ES2878403T3 (es) 2021-11-18
CA2472028C (fr) 2010-03-30
GT200300018A (es) 2003-09-22
HK1074164A1 (en) 2005-11-04
EP1469833B1 (fr) 2021-05-19
JP4865989B2 (ja) 2012-02-01
PA8565301A1 (es) 2003-09-05
TW200302749A (en) 2003-08-16
KR20040079970A (ko) 2004-09-16
UY27640A1 (es) 2003-09-30
BR0307333A (pt) 2004-12-07
US20040185112A1 (en) 2004-09-23
EP1469833A2 (fr) 2004-10-27
US9339467B2 (en) 2016-05-17
US6763607B2 (en) 2004-07-20
US6973741B2 (en) 2005-12-13
JP2009149683A (ja) 2009-07-09

Similar Documents

Publication Publication Date Title
IL162819A0 (en) Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
PL371593A1 (en) Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
ZA200701483B (en) Ball and socket joint and method for producing the same
TWI366385B (en) Method and system for facilitating inter-system handover
HK1075191A1 (en) Apparatus, method and software for tracking an object
EP1590613A4 (fr) Procede de lyophilisation et appareil de production de particules
EP1344562A3 (fr) Appareil pour la production de toner, procédé pour la fabrication de toner et toner
HK1155475A1 (en) Method for producing gamma-carboxylated proteins
AU2003290465A1 (en) Spraying device and method for fluidised bed granulation
EP1649627A4 (fr) Procede et appareil de production de plan
AU2003230167A1 (en) Imaging methods and apparatus particularly useful for two and three-dimensional angiography
AU2002234846A1 (en) Method and apparatus for registration control in production by imaging
EP1711755A4 (fr) Procede, appareil et systeme pour transferer la chaleur
EP1651113A4 (fr) Procede et appareil d'imagerie par ultrasons
EP1497856A4 (fr) Procede de calcination
AU2003294458A1 (en) Method, apparatus, and facility for mri dual scanning
AU2003223360A8 (en) Mid-frame for an imaging apparatus
AU2003202980A1 (en) Apparatus and method for imaging
AU2003252001A1 (en) Methods for sterilizing milk
EP1507781A4 (fr) Methode de preparation de maytansinol
AU2003246993A8 (en) Method for presenting fisheye-camera images
AU2003289203A1 (en) Solid-state imaging device and method for producing solid-state imaging device
AU2003282340A1 (en) Milking apparatus and method for use thereof
AU2003256006A8 (en) Improved process for preparation of risperidone
AU2003304004A1 (en) Method and device for generating spatial images